Causative Relationship Between Drug Abuse And Sexual Dysfunction in Males | ||
| Sohag Medical Journal | ||
| Article 29, Volume 22, Issue 2, July 2018, Pages 239-247 PDF (117.49 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/smj.2018.40609 | ||
| Authors | ||
| Soheir A Mohammed1; Amr Abdelhamed2; Reda M El Sayed1; Mohammed H Mohammed3 | ||
| 1Department of, Forensic Medicine & Clinical Toxicology Faculty of Medicine, Sohag University, Egypt. | ||
| 2Department of, Dermatology, Venereology and Andrology Faculty of Medicine, Sohag University, Egypt. | ||
| 3Department, Faculty of Medicine, Sohag University, Egypt. | ||
| Abstract | ||
| Objectives: Most studies investigate sexual dysfunction in drug abusers. However, no data is available about drug abuse in patients with sexual dysfunction especially in Upper Egypt. Therefore, this study aims to assess the pattern of drug abuse in patients with sexual dysfunction, and its potential impact on hormonal profile. Material and Methods: The study included 100 male patients with history of sexual dysfunction for at least 6 months. Initial evaluation with history, general & local examinations were done. Sexual dysfunction was evaluated with the Arabic version of Sexual health inventory for men (SHIM), Erection hardness score (EHS), and the Arabic Index of Premature Ejaculation (AIPE). Morning blood sample was used for assessment of Total Testosterone (TT), Luteinizing Hormone (LH), and Follicle Stimulating Hormone (FSH). Urine sample was screened by (ABON™ Multi-Drug) dipstick kits for the following drug abuse tramadol, opiate, THC (Cannabis), amphetamine, barbiturate, cocaine and benzodiazepines. Positive results were confirmed by the Immunoassay drug analyzer through the use of specific antibodies. Results: Patients' characteristics showed age 39 (31-45) years with 52% were smoker. Sexual dysfunction complaints included PE (76%), ED (57%), and combined (43%), with average duration of 11 (8-18) months. Patients' hormonal profile showed TT 6.3 (2.67-7.55) ng/ml, FSH 3.5(1.86-5.01) mIU/ml, and LH 3.1(2.1-5) mIU/ml. SHIM, EHS, and AIPE were 15 (12-19), 3 (2-3), and 19(16-24) respectively. Urine screening was positive in 39 % (39/100). Confirmation by drug analyzer revealed 4 patients were false positive. Therefore, the final result for drug abuse was 35% (35/100); with the most common drug was tramadol 19% (19/100) followed by THC (Cannabis) 12% (12/100). Patients with positive drug abuse had significantly higher smoking percent (p=<0.0001), higher driver occupation (p=0.018), and higher positive drug abuse history (p=<0.0001). There were no significant changes in both the sexual dysfunction severity and hormonal profile between positive and negative drug abuse groups. Through binary logistic regression, both smoking (OR=22.39, 95% CI: 4.20- 119.19, p=<0.0001), and history of drug abuse (OR=20.26, 95% CI: 5.21- 78.76, p=<0.0001) are significantly independent predictors for positive drug abuse test. Conclusions: Drug abuse is prevalent among Egyptian male patients with sexual dysfunction, especially tramadol. The drug abuse is common among smoker, and driver occupation. However, no hormonal disturbance could be shown in drug abuse patients. More patient awareness and legal regulations should be considered to reduce drug abuse in Egypt. | ||
| Keywords | ||
| sexual dysfunction; Drug abuse | ||
|
Supplementary Files
|
||
| References | ||
|
[1] World Health Organization. ATLAS on substance use: resources for the prevention and treatment of substance use disorders. Geneva:( 2010). [2] Loffredo CA, Boulos DN, Saleh DA, et al. Substance use by Egyptian youth: current patterns and potential avenues for prevention. Substance use & Misuse. 2015;50: 609-18. [3] Kumsar NA, Kumsar Ş, Dilbaz N. Sexual dysfunction in men diagnosed as substance use disorder. Andrologia. 2016;48: 1229-35. [4] Zaazaa A, Bella AJ, Shamloul R. Drug addiction and sexual dysfunction. Endocrinology and Metabolism Clinics of North America. 2013;42: 585-92. [5] Ajo R, Segura A, Inda MM, et al. Opioids Increase Sexual Dysfunction in Patients With Non-Cancer Pain. The Journal of Sexual Medicine. 2016;13: 1377-86. [6] Shamloul R, Bella AJ. Impact of cannabis use on male sexual health. The Journal of Sexual Medicine. 2011;8: 971-5. [7] Shamloul R, Ghanem H, Abou-zeid A. Validity of the Arabic version of the sexual health inventory for men among Egyptians. International Journal of Impotence Research. 2004;16: 452-5. [8] Arafa M, Shamloul R. The Arabic version of the Erection Hardness Score. The Journal of Sexual Medicine. 2009;6: 3501-3. [9] Arafa M, Shamloul R. Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). The Journal of Sexual Medicine. 2007;4: 1750-6. [10] Vallejo-Medina P, Sierra JC. Effect of drug use and influence of abstinence on sexual functioning in a Spanish male drug-dependent sample: a multisite study. The Journal of Sexual Medicine. 2013;10: 333-41. [11] Abdel-Hamid IA, Andersson KE, Waldinger MD, Anis TH. Tramadol Abuse and Sexual Function. Sex Med Rev. 2016;4: 235-46. [12] Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesthesia and Analgesia. 2017;124: 44-51. [13] Bassiony MM, Salah El-Deen GM, Yousef U, et al. Adolescent tramadol use and abuse in Egypt. The American Journal of Drug and Alcohol Abuse. 2015;41: 206-11. [14] Hamdi E, Gawad T, Khoweiled A, et al. Lifetime prevalence of alcohol and substance use in Egypt: a community survey. Substance Abuse. 2013;34: 97-104. [15] Hadland SE, Levy S. Objective Testing: Urine and Other Drug Tests. Child and Adolescent Psychiatric Clinics of North America. 2016;25: 549-65. [16] Bassiony MM, Abdelghani M, Salah El-Deen GM, Hassan MS, El-Gohari H, Youssef UM. Opioid Use Disorders Attributed to Tramadol Among Egyptian University Students. Journal of Addiction Medicine. 2018;12: 150-55. [17] Lai S, Lai H, Page JB, McCoy CB. The association between cigarette smoking and drug abuse in the United States. Journal of Addictive Diseases. 2000;19: 11-24. [18] Abdelazim S, Abolmagd SF, Abdalla H, Enaba DA, Elsheikh SM, Moselhy HF. Sexual Dysfunction and Sex Hormone Levels in Egyptian Opioid-Dependent Males American Journal of Pharmacy & Health Research. 2015;3: 81-91. [19] La Pera G, Carderi A, Marianantoni Z, Peris F, Lentini M, Taggi F. Sexual dysfunction prior to first drug use among former drug addicts and its possible causal meaning on drug addiction: preliminary results. The Journal of Sexual Medicine. 2008;5: 164-72. [20] Calsyn DA, Baldwin H, Niu X, Crits-Christoph P, Hatch-Maillette MA. Sexual risk behavior and sex under the influence: an event analysis of men in substance abuse treatment who have sex with women. The American Journal on Addictions. 2011;20: 250-6. | ||
|
Statistics Article View: 335 PDF Download: 329 |
||
